The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,947.00
Bid: 1,946.00
Ask: 1,947.00
Change: -12.00 (-0.61%)
Spread: 1.00 (0.051%)
Open: 1,942.00
High: 1,950.00
Low: 1,938.00
Prev. Close: 1,959.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Banks, insurance dodge carnage as real estate stocks sink

Thu, 03rd Nov 2022 09:28

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

BANKS, INSURANCE DODGE CARNAGE AS REAL ESTATE STOCKS SINK (0818 GMT)

Europe's STOXX 600 is flashing red as signalled by earlier futures trading, last down 0.9% after U.S. markets took a battering on Wednesday.

Only two sectors are spared from the carnage; banks are up 0.3%, and insurance is up 0.2%.

The former is helped out by the Netherlands' largest bank ING Groep which has rallied 5.5% after reporting Q3 results and rolling out a share buyback plan worth 1.5 billion euros ($1.46 billion).

A 2.7% lift for BNP Paribas after Q3 profits topped forecasts can't hurt either.

The two banks are also helping to stem losses on the STOXX 600 and are the two biggest positive weights in the index. Meanwhile, insurer AXA is up 1.7%.

But the share price outperformer is Denmark-based IT consultancy company Netcompany , with shares rising 20.5% after some upbeat Q3 financials.

The UK's Hikma Pharmaceuticals, up 5.5%, is also helping lift the index after reiterating 2022 guidance in a trading statement.

Real estate stocks are down 2.5%, and in what is a familiar story in recent months. They're also the worst performing sector , followed closely by autos travel and tech, all down about 2%.

Dutch semiconductor maker ASML is providing the biggest drag on the broader STOXX 600, down 3.3%, as are Danish healthcare company Novo Nordisk and France's LVMH , down 1.6% and 1.7% respectively.

Thyssenkrupp shares are down 8.9% after Deutsche Bank cut the German submarine-to-steel group to "hold" from "buy", citing macroeconomic difficulties and an overly complex group structure.

ONE CENTRAL BANK DRAMA AFTER ANOTHER (0745 GMT)

So, Jerome Powell found a way to quiet the endless market chatter of a pivot even as he opened the door to smaller hikes.

Clearly the Fed chief doesn't want the bond market to rally so much that it eases U.S. financial conditions while inflation is still running hot. Ironically, the more bonds price in a pivot, the less inclined the Fed will be to give them one.

As a result, May Fed funds have shifted to 5.08% from 4.90% at end of last week, and there's less chance of a cut priced in by late next year. The yield curve bear-flattened and has not been this inverted since the turn of the century.

Now it's time for the Old Lady of Threadneedle Street to enter stage right and do her routine for the cameras. The Monetary Policy Report is out at noon (1200 GMT), followed by a news conference half an hour later streamed live on the Bank of England's website.

Markets are priced for a hike of 75 bps to 3.0%, which amazingly would be the highest since 2008. What happened to the goode olde days of 10%-plus?

Some are tipping 50 bps, but that would risk markets concluding the BoE isn't serious about taming inflation and spooking gilts again. Equally, 100 bps would just fan fears of a much deeper recession and an even bigger budget black hole.

In any event, the BoE is going to have to revise up its CPI forecasts and slash those for GDP, which will make for gloomy viewing compared to the comedy show that is government policy right now.

Other key developments that could influence markets on Thursday:

U.S. initial jobless claims seen at 220K

ISM service sector PMI is forecast at 55.5

Earnings include ConocoPhillips, Kellogg, Starbucks

STOXX POISED TO FALL AS MARKET DIGESTS FED, TURNS TO BOE (0739 GMT)

European stocks are set for a fall of 1.1% at the open, as the market continues to digest the "double-sided message" delivered by the Fed on Wednesday which saw U.S stocks shed 2.5% into the close after initially rising following an expected 75-bps rate hike.

Attention turns to the Bank of England's midday rate announcement. Market expectations centre on a similar hike of 75 bps - which would be the central bank's largest since 1989 as it battles the highest inflation in 40 years.

Earnings season continues, with euro zone's biggest lender BNP Paribas posting a higher-than-expected net profit in the third quarter.

German premium carmaker BMW has reported better than expected quarterly net profit - thanks to high car prices - but warned that rising inflation and interest rates would start to weigh on sales in the coming months.

Higher costs for energy and raw materials, as well as a weakening building materials market are behind a potential 10% drop in 2022 operating profit for the world's No. 2 cement maker Heidelberg Materials.

Meanwhile one of the biggest net losses in German corporate history of 40 billion euro ($39.3 billion has been unveiled by soon-to-be-nationalised gas importer Uniper.

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.